A controlled prospective trial of antithoracic duct lymphocyte globulin (ATDLG) for treatment of severe aplastic anemia.
D000741:Anemia, Aplastic / Q000097:blood / Q000628:therapy*; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use*; D001772:Blood Cell Count; D002986:Clinical Trials as Topic; D006801:Humans; D007165:Immunosuppression Therapy; D007700:Kinetics; D011446:Prospective Studies; D013897:Thoracic Duct / Q000166:cytology / Q000276:immunology*
D000961:Antilymphocyte Serum